Clinical Director of the National Institute of Drug Abuse Dr. Lorenzo Leggio, said GLP-1 drugs' effect on the brain can help curb the desire for drinking.
Responses were rapid and durable, and tumor shrinkage was observed in 82 percent of patients New findings from this investigational study build on the strength ...
Hosted on MSN
Can GLP-1 drugs make beer and liquor less desirable?
GLP-1s seem to have more malleable uses than what they were created for. Popular drugs like Ozempic, Wegovy, and Mounjaro are meant for diabetic patients, but in recent years, people have leaned on ...
Rani Therapeutics secured a $1.085 billion collaboration with Chugai Pharmaceutical. Check out why I am initiating with a Buy rating on RANI stock.
RAPT Therapeutics, Inc. ( NASDAQ: RAPT) Discusses Top Line Phase II Results for RPT-904 in Chronic Spontaneous Urticaria October 20, 2025 8:30 AM EDT Good morning, and welcome to RAPT's conference ...
Balazs Halmos, MD, discussed the potential impact of subcutaneous amivantamab for patients with EGFR-mutated NSCLC. Halmos oversees the thoracic clinical trials program of novel clinical studies at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback